This was hidden! Hehehe!
$Eton Pharmaceutical(ETON.US$ Eton Pharmaceuticals Acquires Exclusive U.S. Rights To PKU GOLIKE From Relief Therapeutics, Expects To Be Accretive To Earnings In 2024
Moomoo 24/7· 02:29
Eton Pharmaceutical PKU GOLIKE is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call point
Transaction is expected to be accretive to 2024 earnings
Estimated peak sales of more than $10 million annually
U.S. phenylketonuria ("PKU") medical formula market estimated to be $100 million annually
Moomoo 24/7· 02:29
Eton Pharmaceutical PKU GOLIKE is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call point
Transaction is expected to be accretive to 2024 earnings
Estimated peak sales of more than $10 million annually
U.S. phenylketonuria ("PKU") medical formula market estimated to be $100 million annually
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
73168262 : And yet very little volume